| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −19.3× | −7.3× | |
| Price / Book | −13.3× | 3.2× | |
| Price / Sales | 83.1× | 233.4× | |
| Price / Free cash flow | −25.6× | −10.2× | |
| EV / EBITDA | −20.9× | −24.4× | |
| Earnings yield | −5.2% | −9.7% | |
| Free cash flow yield | −3.9% | −0.8% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $19.00 | +1.55% | $1.71B | −25.5× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $31.14 | −3.83% | $1.42B | −418.0× | −38.8% | +1266.2% |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.91 | +1.19% | $735.71M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $13.94 | +1.53% | $636.38M | −10.3× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $14.20 | +1.87% | $451.35M | −7.3× | 46.0% | — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $16.21 | +11.56% | $240.8M | −149.3× | 157.3% | — |
BSNAS:BSEMBioStem Technologies, Inc. · 🇺🇸 NAS | $1.54 | −26.32% | $27.49M | −5.7× | −16.8% | −56.7% |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.63 | −4.12% | $12.37M | −0.6× | −560.2% | +150.0% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $2.81 | −1.41% | $2.93M | −0.3× | −65.3% | +95.2% |
